South Korea
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 140.06
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
2 |
USD 139.08
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
3 |
USD 109.46
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
4 |
USD 100.77
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
5 |
USD 92.46
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
6 |
USD 90.22
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
7 |
USD 83.61
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
8 |
USD 57.47
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
9 |
USD 47.55
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
10 |
USD 39.87
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
11 |
USD 35.33
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
12 |
USD 33.71
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
13 |
USD 29.16
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
14 |
USD 28.74
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
15 |
USD 25.36
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
16 |
USD 23.36
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
17 |
USD 22.45
|
Dec. 31, 2023 | USD 14.37 | -3.79% |
|
South Korea |
|
18 |
USD 19.90
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
19 |
USD 19.29
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
20 |
USD 17.86
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
21 |
USD 17.33
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
22 |
USD 14.10
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
23 |
USD 12.77
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
24 |
USD 11.73
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
25 |
USD 11.64
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
26 |
USD 11.59
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
27 |
USD 11.04
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
28 |
USD 10.53
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
29 |
USD 10.04
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
30 |
USD 10.02
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
31 |
USD 10.02
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
32 |
USD 9.17
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
|
33 |
USD 8.57
|
Dec. 31, 2023 | USD 10.66 | -1.34% |
|
South Korea |
|
34 |
USD 8.20
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
35 |
USD 7.87
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
36 |
USD 7.83
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
37 |
USD 7.57
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
38 |
USD 6.84
|
Dec. 31, 2023 | USD 3.22 | 0.07% |
|
South Korea |
|
39 |
USD 6.48
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
40 |
USD 6.33
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
41 |
USD 5.98
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
42 |
USD 5.13
|
Dec. 31, 2023 | USD 3.25 | -3.09% |
|
South Korea |
|
43 |
USD 4.69
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
44 |
USD 4.54
|
Dec. 31, 2023 | USD 8.02 | 4.65% |
|
South Korea |
|
45 |
USD 3.87
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
46 |
USD 3.70
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
47 |
USD 3.48
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
48 |
USD 3.00
|
Dec. 31, 2023 | USD 6.88 | -1.99% |
|
South Korea |
|
49 |
USD 2.53
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
50 |
USD 2.29
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
The Healthcare company in South Korea with the highest Revenue Per Share is Chong Kun Dang Holdings Corp. (KSE: 001630.KS) at USD 140.06.
The Healthcare company in South Korea with the lowest Revenue Per Share is Cellid, Co., Ltd. (KOSDAQ: 299660.KQ) at USD 0.00.
The top 10 Healthcare companies in South Korea by Revenue Per Share are Chong Kun Dang Holdings Corp., Dong-A Socio Holdings Co., Ltd., Green Cross Corporation, Chong Kun Dang Pharmaceutical Corp., Daewoong pharmaceutical Co.,Ltd, Hanmi Pharm. Co., Ltd., iMarketKorea Inc., Dong-A ST Co., Ltd., Huons Global Co., Ltd. and Samsung Biologics Co.,Ltd..
The bottom 10 Healthcare companies in South Korea by Revenue Per Share are Cellid, Co., Ltd., MedPacto, Inc., SillaJen, Inc., CrystalGenomics, Inc., Helixmith Co., Ltd, Genexine, Inc., Oscotec Inc., Peptron, Inc., PCL, Inc. and EOFLOW Co.,Ltd..